Wednesday, February 10, 2010, 6:48pm SGT - The Singapore stock market is closed.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

ev3, Inc. (EVVV)

At 5:00AM SGT: 14.22 USD   0.00 (0.00%)  
 MORE ON EVVV 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 ev3 Inc. (NasdaqNM:EVVV) Delayed quote dataEdit
Last Trade:14.22 USD
Trade Time:5:00AM SGT
Change: 0.00 (0.00%)
Prev Close:14.22
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:14.40
Day's Range:N/A - N/A
52wk Range:5.05 - 15.69
Volume:0
Avg Vol (3m):721,011
Market Cap:1.60B
P/E (ttm):N/A
EPS (ttm):-2.46
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y 
Use Y! Toolbar to track stocks
 Add EVVV to Portfolio   Download Data

 HEADLINES 
•Leading Home Health Care Industry Analyst Forecasts Significant Rise In Home Health Care And Diagnostics Companies Acquisitions In 2010
Wall Street Transcript (Wed, Feb 3)
•Director Richard Emmitt Sells $8.8M Worth of EV3
at TheStreet.com (Wed, Jan 20)
•Cardiovascular Systems Get Approval
Zacks.com (Fri, Jan 15)
•EV3 INC. Files SEC form 8-K, Regulation FD Disclosure
EDGAR Online (Tue, Jan 12)
•ev3 Completes Catheter Recall
Zacks.com (Thu, Jan 7)
•ev3 recalled catheters in December due to cracks
AP (Wed, Jan 6)
•ev3 Announces Completion of Voluntary Recall
GlobeNewswire (Wed, Jan 6)
•ev3 to Present at the 28th Annual J.P. Morgan Healthcare Conference on January 12, 2010
GlobeNewswire (Wed, Jan 6)
•Zacks #1 Rank Additions for Thursday
Zacks.com (Thu, Dec 24)
•EV3 INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
EDGAR Online (Wed, Dec 16)
•ev3 Announces Promotion of Two Senior Executives
GlobeNewswire (Wed, Dec 16)
•ev3 Inc. to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009
GlobeNewswire (Wed, Nov 25)
•ev3 Inc. to Present at the 2009 Citi Investment Research Small and Mid Cap Conference on November 19, 2009
GlobeNewswire (Fri, Nov 13)
More Headlines for EVVV...
 ANALYST 
EPS Est (next year) (Dec-09) :0.23
EPS Est (in 2 years) (Dec-10) :0.47
Avg Rec (current)*:2.4
PEG Ratio:2.11
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
ev3 Inc. operates as an endovascular company that focuses on identifying and treating peripheral vascular disease, including lower extremity arterial disease and neurovascular disease.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices